ENIGMA-TRS 1 is an international, one-year, double-blind, placebo-controlled Phase III study in at least 600 patients; enrollment to start imminently; 12-week study results expected in Q4 2026 ...

STAMFORD, Conn., April 11, 2006 (PRIMEZONE) -- Enigma Software Group, Inc. (OTCBB:ENGM), ("Enigma" and/or the "Company"), which yesterday filed its annual report to the Securities and Exchange ...

CLEARWATER, Florida, March 3, 2017 /PRNewswire/ -- Enigma Software Group USA, LLC ("ESG") announced that it reached a settlement in the lawsuit it filed last year against Bleeping Computer LLC. The ...

What just happened? Enigma Software Group has won a crucial case in the U.S. Court of Appeals for the Ninth Circuit, allowing it to proceed with its lawsuit against Malwarebytes for flagging its ...

Many, many years ago, when PCs were a lot newer to the world and I was slightly younger (I claim reverse dog years), I remember my father came up with the idea of software to manage equipment ...

Malwarebytes is celebrating victory after a US judge ruled in its favor in a legal battle with a software company over potentially unwanted programs (PUPs). District Judge Edward Davila dismissed ...

On June 2, 2023, the Ninth Circuit reversed a dismissal of Plaintiff Enigma Software Group’s (“Enigma”) Lanham Act false advertising and related state law claims against its competitor, Defendant ...

Florida-based Enigma Software Grp. USA LLC markets the SpyHunter anti-malware computer program. Santa Clara, California-based competitor Malwarebytes' own Anti-Malware (MBAM) detects and removes ...

Ars Technica has been separating the signal from the noise for over 25 years. With our unique combination of technical savvy and wide-ranging interest in the technological arts and sciences, Ars is ...